SELLAS Life Sciences Group Inc (FRA:RXK3)
€ 1.066 -0.002 (-0.19%) Market Cap: 68.93 Mil Enterprise Value: 61.15 Mil PE Ratio: 0 PB Ratio: 23.30 GF Score: 37/100

Sellas Life Sciences Group Inc at UBS Global Healthcare Conference (Virtual) Transcript

May 18, 2020 / 08:40PM GMT
Release Date Price: €2.73 (-0.51%)
William Erwin;UBS;Investment Banking Analyst

Good afternoon and thank you for coming to the 2020 Virtual UBS Global Healthcare Conference. My name is Will Erwin, and I'm going to be your host for this session.

Our next presenter will be Angelos Stergiou, Chief Executive Officer at SELLAS Life Sciences.

Q&A session will follow immediately after the presentation. (Operator Instructions) We now turn it over to Angelos. Thank you.

Angelos M. Stergiou
SELLAS Life Sciences Group, Inc. - Founder, President, CEO & Director

Will, thank you very much, and good afternoon, and thank you, everyone, for joining us today for our corporate presentation of SELLAS Life Sciences.

Firstly, I'd like to thank our UBS colleagues for coming through with a virtual healthcare conference amid COVID-19. And I hope that everybody is safe and healthy. I'm Dr. Angelos Stergiou, President and CEO of SELLAS.

Slide 2. During today's discussion, we may make forward-looking statements around our company and business, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot